FDA Drug recall D-0726-2022
Atorvstatin Calcium Tablets, USP 80 mg*, 90 Tablets, Rx Only, Mrd
- FDA Drug
- Class III
- terminated
- Published 2022-04-06
On 2022-04-06 the FDA classified a Class III recall of Atorvstatin Calcium Tablets, USP 80 mg*, 90 Tablets, Rx Only, Mrd by Dr Reddy S Laboratories, citing failed Impurities/Degradation Specifications: Out of Specification results for related substance.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0726-2022 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2022-03-16 |
| Published | 2022-04-06 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Dr Reddy S Laboratories |
| Distribution | US |
Product
Atorvstatin Calcium Tablets, USP 80 mg*, 90 Tablets, Rx Only, Mrd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409, INDIA, NDC 55111-124-90
Reason
Failed Impurities/Degradation Specifications: Out of Specification results for related substance.
Identifiers
| ndc | 55111-124-30 |
|---|---|
| ndc | 55111-124-60 |
| ndc | 55111-124-90 |
| ndc | 55111-124-05 |
| code_info | Lot: T000707, T000756, T000758, T000759, Exp 03/2022; T2100600, T2101075, Exp. 1/2023; T2102802, Exp. 07/2023 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0726-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.